Regulation of Food Intake : A Complex Process by Jain, Swati & Singh, Som Nath
182
1. IntroductIon 
Increasing focus on obesity necessitates determination 
of basic epidemiological evidence and clinical data so as to 
provide enhanced care and management towards this disease. 
Psychobiological and neuroendocrine systems involved 
in regulation of food intake could contribute to a better 
understanding of obesity. A holistic health care approach 
encompassing these theoretical and supporting evidences 
should be adopted for well- being of obese individuals. 
2.  EatIng bEhavIour 
The complex interplay between hunger, appetite and 
satiety reflect about the eating behavior. The concepts of food 
intake and eating behavior are distinct. While food intake refers 
to ‘what we eat’, eating behavior refers to ‘how we eat’. Food 
intake is a biological phenomenon that intends to maintain the 
energy balance of the body, eating behavior is an environmental 
phenomenon affecting the dietary preferences and food induced 
hedonic effect1,2. Energy intake is affected by various factors and 
characteristics of the food environment (Fig. 1) for example the 
calorie consumption is more when the meals consist of variety 
of foods, availability of more palatable and energy dense items 
in menu. 
The choice of food to be consumed and the amount of 
food to be eaten are the two basic decisions involved during the 
process of eating. Different behaviors, signals and physiological 
mechanisms control food choice and food intake3. Studies with 
animals demonstrate that learning can cause conditioning and 
result in association of non-food cues with eating for example as 
seen in Pavlov’s experiment with dogs. Humans eat for various 
reasons; it is not only to satisfy their appetite but also due to 
sensory hedonics, social pressure, and boredom. The complex 
interactions between biological mechanisms of appetite control 
and challenges posed by environment determine our drive to eat. 
Feeding behavior is controlled by a variety of signals4. Cephalic 
signals such as taste, smell, sight of food and gastrointestinal 
signals resulting from gut peptide release can have an effect on 
food intake consumed in the short term. 
The synchronous operations of the processes at the three 
levels of psychobiological system affect appetite. These levels 
are - psychological episodes and behavioral functions; the level 
of peripheral physiology and metabolic events and; finally at 
the brain level. Cravings, perception of hunger and behavioral 
functions like intake of meals, and macronutrients form the 
part of psychological episodes and behavioral operations4. The 
lower part of the psychobiological system describes the appetite 
cascade through behavioral actions which actually form the 
structure of eating, and prompts the events that stimulate eating 
as well as occur post consumption of a meal. 
‘Liking’ and ‘wanting’ are emerging constructs in a 
conceptual approach to food hedonics. The relationship between 
hedonic and homeostatic drives arising from biological needs is 
a key issue in the study of appetite control. Some researchers 
suggest that a clear distinction between the two concepts may 
not be possible, as the changes in either of the two, may affect the 
Figure 1. Factors affecting eating behaviour.
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other. Nevertheless, liking and wanting have distinct identities 
too, which signify their role as major deciding factors, affecting 
the control on eating and therefore on overconsumption.  It is 
the ‘liking’ that motivates consumption of food, but once it 
is held, the construct of ‘wanting’ in an existing obesigenic 
environment, promotes excess consumption and consequently 
could result in weight gain.
With clinical observations now the concepts of hunger and 
appetite can be distinguished. Hunger is the physiological need 
for nutritional replenishment, arising out of metabolic reactions 
beginning at the cellular level for eg. during calorie restriction5. 
Appetites is a function of the brain and the psychological desire 
to eat. 
Paspala2, et al. have described that each meal can be 
considered as consisting of three phases: 
Initiation of food intake - Stomach contractions, food taste 
and energy levels are the biological mechanisms involved in 
initiation of a meal. For several years, stomach contractions were 
regarded as the main stimulus to induce appetite. The taste of the 
food and food choice play a key role in food preference as well. 
There are certain signals in the body’s circulation that reflect 
energy reserves and depict energy balance. In obese individuals, 
however, due to insulin resistance, a misleading signal of lack of 
food may result in more over consumption. 
Meal duration - Duration of a meal depends on internal 
and external mechanisms. Stimuli from mouth, pharynx 
and esophagus may cause extension of the meal. While, the 
exogenous factors that could influence meal duration are the 
appearance of the food, its taste and smell. 
End of meal - The digestion process starts in the stomach 
where the digestive system hormones control the process and 
leads to the end of meal. Specialized chemo- and mechano-
receptors in the gI system monitor physiological activity 
and transfer information to the brain. This process might get 
influenced through the amino acids in the circulation that act as 
peripheral signals to the brain. 
3. aPPEtItE rEgulatIon
3.1 theories behind appetite regulation
3.1.1 The Glucostat Theory
An early attempt to explain the plausible mechanisms 
controlling hunger and satiety focused on glucose. It was 
proposed that the hypothalamic nuclei were able to detect 
changes in blood glucose levels and induced and decreased food 
intake accordingly during hypoglycemia and hyperglycemia 
respectively. This hypothesis was called the ‘glucostat theory’6. 
When glucose levels fall below the threshold, neuronal activity 
in the appetite center increases and need for the next meal is felt. 
The glucostat theory regulates short-term control over appetite. 
However due the simplicity of the theory it was abandoned. 
3.1.2 The Dual-Centre Theory 
Describes the occurrence of hunger and satiety as related to 
the blood glucose levels. It was first formulated in the 1950s and 
involves two centres of the brain –Ventro medial hypothalamus 
(VMH) and Lateral hypothalamus (LH). The VMH and LH act 
as satiety and hunger centres respectively. After a meal, when the 
glucose levels rise, VMH is activated and initiates satiety, on the 
other hand LH induces hunger, by producing ghrelin hormone 
(Fig. 2), when the blood sugar levels drop. Animal experiments 
have shown that when LH and VMH centres are lesioned, there 
is an associated decrease in food intake. However, gold7found 
that lesions on VMH alone did not result in hyperphagia as other 
regions like the paraventricular nucleus were also involved. 
Lashley8 found that rats who had their VMH lesioned had 
developed over eating which soon led to obesity.
Figure 2. dual control mechanism as part of the glucostatic 
theory
Pinel9 has provided a contemporary view on the role of 
LH and VMH. He has provided a complementary explanation 
for the role of the VMH in feeding. He proposed that animals 
with VMH lesions ‘overeat because they become obese’. He 
argued that VMH lesions increases blood insulin levels thereby 
triggering lipogenesis. Therefore, a state of energy deficiency 
sets in because any food that is eaten is rapidly converted into 
fat. Consequently the food eaten goes in vain to overcome the 
lack of blood glucose. The ‘Dual Control Theory’ has not been 
fully accepted owing to the incongruities of lesion- hypothesis, 
nevertheless it has given a useful insight of feeding behaviour. 
3.1.3 The Lipostat Theory
The hypothesis of this theory is of energy balance. It 
proposed that adipose tissue generates fatty acids and glycerol 
by lipolysis, which circulate in the blood and act on the brain to 
maintain energy expenditure, thereby controlling body weight. 
Thus, increased lipolysis rates led to eating and a post prandial 
decrease in lipolysis resulted in its termination10. The secretion 
of leptin hormone also occurs in proportion to the size of the fat 
cells. It is inferred that the fatter the animal, the more would be 
the secretion of this hormone and greater should be the satiety. 
This decreased feeling of hunger would remove the extra weight 
and return to its set weight. 
3.1.4 The Aminostatic Theory
Mellinkoff 11, et al. proposed that the amino acids produced 
after the breakdown of protein stores send signals to the brain for 
energy balance. This denotes that an increased muscle catabolism 
would result in raised levels of amino acids and therefore, would 
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stimulate feeding. On the other hand, diminished amino acid 
levels signify end of feeding and satiety. 
Another model was based on energy rich molecules 
as ATP and changes in body temperature12. Hunger would 
be a consequence of low ATP production and reduced body 
temperature. This hypothesis was discarded too as it could not 
be applied to normal life situations. 
3.2 Episodic and tonic signals for appetite 
regulation
The short term and long term regulation of appetite, has 
also been designated as the episodic and tonic signals13. As 
the name suggests, episodic signals are usually generated by 
episodes of eating and undulate with the eating pattern. They 
can be excitatory or inhibitory in nature. Tonic signals, arise 
from tissue stores like adipose tissue and exert a tonic pressure 
on appetite manifestation. These signals together are integrated 
within complex brain networks that control the overall expression 
of appetite. 
3.3  Energy balance approach 
The Energy Balance Approach suggests that the food intake 
of an individual must match his energy expenditure, in order to 
regulate the body weight. Taking this view forward, Blundell14, 
et al. explained in what manner body composition and energy 
expenditure control hunger and appetite.
The molecular approach for appetite control has an 
alternative to it now. Fat free mass and resting metabolic rate 
determine the drive to eat that reflects the body’s demand for 
energy, which is sequentially determined by the tonic inhibition 
from leptin. Leptin insensitivity also occurs as a result of higher 
adipose tissue, which reduces the tonic inhibition. Certain gI 
peptides, released post-prandially, act as episodic signals and 
suppress the drive to eat. Besides, physical exercise has a dual 
action on hunger, for instance prolonged exercise may have 
hunger stimulating effects, whilst also increasing post-prandial 
satiety signaling15.
It can be inferred that appetite regulation thus, comprises 
of tonic drives and tonic inhibition signals as well as episodic 
signals starting from the mouth and gI tract.
3.4 the brain/hypothalamic circuitry in central 
regulation of Energy homeostasis
Apart from the psychobiological factors, there is also a 
brain phase in the food intake process. Discoveries in mammals 
concerning the endocrine control of appetite and growth have 
led to a new understanding of how the metabolic demand for 
energy is regulated in the CNS. Neural circuits integrate the 
peripheral signals with neurotransmitters within the brain. Brain 
areas involved in feeding regulation:
Hypothalamus is the regulating center of appetite and 
energy homeostasis16.Though most research has been focused on 
NPY and POMC, the other centers , interconnecting nuclei of the 
brain are ventromedial nucleus (VMN), lateral hypothalamic area 
(LHA), arcuate nucleus (ARC), paraventricular nucleus (PVN), 
and the dorsomedial nucleus (DMN). 
The effect of ghrelin and leptin is mediated by NPY/AgRP 
neurons. Leptin receptors are also found on POMC neurons. 
Both of these neurons are regulated by leptin in an opposing 
manner as this hormone inhibits NPY and stimulates POMC. 
This regulation by leptin is antagonized by ghrelin as these 
neurons are stimulated by ghrelin17. Consequently, gHRL-NPY-
AgRP axis controls appetite, while the LEP-POMC-CART 
axis is thought to control satiety. Signals within the CNS are 
integrated with peripheral signals in the hypothalamic centers 
as they adjust to nutrient availability giving information about 
actual energy stores and needs. The antagonism of each opposing 
neuropeptide system maintains a sophisticated control. The 
PVN neurons synthesize and secrete neuropeptides that have a 
net catabolic action, have neurons which express the anorectic 
factors, thyrorotropin and corticotropin releasing hormones. 
Additionally, PVN sends signals to liver and adipose tissue for 
increased lipolysis18. 
The VMN contains neurons that sense glucose and leptin 
and it has been shown that destruction of VMN could cause 
hyperphagia, hyperglycemia and obesity. VMN is considered 
to generate satiety and glucose homeostasis. Unlike, PVN 
and VMN, obliteration of LHA causes hypophagia and body 
weight loss weight. As, LHA contains two neuronal orexigenic 
peptides, the melanin concentrating hormone and orexin is also 
considered to be a feeding center19. 
The feeding circuitry involves certain parts of the 
forebrain region which are essential in integrating feeding, 
reward, and motivation to eat. These are telencephalic areas, 
amygdala, hippocampus and prefrontal cortex and the lateral 
hypothalamus. Correspondingly, amygdalar circuitry supports 
termination of feeding20.
Brain stemplays an important role in food intake and hence 
energy balance. Dorso-vagal complex situated in the brain stem 
relays peripheral signals of satiety from the gastrointestinal tract 
to the hypothalamus. Both ascending and descending brain stem-
hypothalamus pathways are important in control of food intake. 
The hindbrain has equal importance in energy homeostasis. 
The lesions of the area postrema or vagotomy have effects of 
various gut hormones and attenuate their effect on food intake. 
Collectively, these findings suggest that food intake is controlled 
through brainstem-mediated mechanisms. Vagus nerve also 
plays a central role in regulating the feeding through variety of 
receptors within the brain stem. The gut hormone signals such 
as CCK, ghrelin, PYY are also transmitted through the vagus 
nerve20,21. 
3.5 biomarkers of satiation in cns neuropeptide 
Y (nPY) 
NPY is a 36 amino acid peptide which is widely spread 
throughout the brain as well as the peripheral nervous system 
where it is often co-localized with nor epinephrine and other 
neurotransmitters. There are five receptors for NPY and 
its related peptides present in mammals. It increases in the 
peripheral blood after a meal. NPY expression has been shown 
to be increased in ARC of the hypothalamus, in food restricted 
animals23. Findings from comprehensive studies have suggested 
that NPY exhibits a lesser role in regulation of food intake under 
normal laboratory conditions but could be imperative for fasting 
induced re-feeding24. NPY acts at multiple sites within the brain 
like PVN and LH to increase food intake, besides it is the level 
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of different Y receptors present at the time of NPY release that 
causes downstream effects of NPY. 
α – Melanocyte stimulating hormone (α- MSH) - This 
is a cleavage product of pro-opiomelanocortin gene. It has 
two receptors in the brain: MC3R and MC4R. Although 
evidence suggests both these receptors are involved in appetite 
regulation, the MC4R is usually considered more important in 
this context25.
Agouti related peptide (AgRP) - AgRP acts as an antagonist 
at the α- MSH receptors, and thus stimulates appetite even in the 
absence of α- MSH. Under the influence of an obesigenic factor, 
over expression of AgRP leads to obesity. However, there are 
opposing views regarding the physiological role of this peptide 
on feeding26.
3.6  Peripheral signals 
The gut has an essential function, in maintaining energy 
homeostasis along with its digestive and absorptive functions in 
the body. It is regarded as the largest endocrine organ. 
3.6.1 Gut Hormones
Cholecystokinin (CCK) - Cholecystokinin is known 
to be the foremost gut hormone which has implications in 
appetite control. Though synthesised in the small intestine and 
is secreted post-prandially, it mediates satiety through CCK 
receptors spread all over the central nervous system. Research 
has shown that intravenous injection of CCK reduces meal 
size and duration in rats as well as in case of humans. Other 
physiological functions of CCK are stimulating the release of 
enzymes, promoting gastrointestinal motility, and delaying 
gastric emptying. CCK along with leptinproduces short term 
inhibition in food consumption and long term reduction of 
body weight; as a result it has been investigated as a potential 
therapeutic target for obesity22.
ghrelin - ghrelin is a 28 amino acid peptide and the 
only orexigenic gut hormone identified till date. Ghrelin 
appears in two forms – total ghrelin which does not possess 
any endocrine action and octanoylated ghrelin which exerts 
its action on gastrointestinal function and appetite. ghrelin is 
produced in the stomach mainly from the fundic region and is a 
growth hormone releasing agent. ghrelin also induces feeding 
and modifies body energy composition. Ghrelin synthesis is 
regulated by nutritional status. Plasma ghrelin concentrations 
are in proportion to the amount of calories ingested, in contrast 
to other gastrointestinal hormones27. The blood levels increase in 
fasting , and in starvation and anorexia nervosa, and after acute 
caloric intake levels decrease. ghrelin increases rapidly before 
eating and therefore acts as a meal initiator and declines when 
food is ingested. The suppression of ghrelin occurs in response 
to administration of nutrients into the stomach, duodenum and 
carbohydrate and protein appear to be more potent suppressors 
of ghrelin than fat28. Intravenous glucose but not lipid has been 
known to suppress ghrelin secretion29. ghrelin via effect on 
neurons in the hypothalamus stimulates hunger. 
Pancreatic polypeptide (PP) - This peptide is secreted from 
the pancreatic islets of Langerhans post meal consumption. It 
is also known to act through the vagus nerve, as vagotomy in 
rodents have exhibited the anorectic effects of PP. Peripheral 
administration of PP for acute and chronic duration reduces food 
intake in mice and in humans. Furthermore, it has been observed 
that the plasma PP levels are lower in early morning and highest 
in the morning30.
Peptide Tyrosine Tyrosine (PYY) – This peptide has a 
typical Tyrosine (Y) residue, depicting its name. It is secreted 
from the ileum, rectum and colon and its release is increased 
in proportion to calorie intake. It acts directly through the 
hypothalamic region. While the circulating levels of PYY are 
low in fasted state, they increase rapidly after a meal, and persist 
raised up for several hours31.
glucagon like Peptide-1 (gLP-1) - gLP-1 is secreted 
along with PYY from the ileum and colon. Verdich et al.32has 
shown reduction in food intake in lean and obese subjects on 
intravenous infusion of gLP-1. Its effects are exerted through 
gLP-1 receptor which is widely distributed in brain, gI tract and 
pancreas. GLP-1 also acts on pancreatic β-cells and stimulates 
glucose-dependent insulin secretion. Its levels are known to rise 
in anticipation of a meal33. 
Oxyntomodulin (OXM) - OXM is a 37-amino acid 
peptide, secreted by the L-cells of the distal gastrointestinal 
tract as a response to food intake and proportionate caloric load. 
Though it exhibits glucagon like activity in liver, it has moderate 
anorexigenic actions in rodents and humans but with a much 
lower potency when compared with gLP-122.
3.6.2 Adiposity signals 
Adiposity signals are produced in proportion to adipose 
stores. The increased levels of leptin and insulin reflect these. 
They reduce the food intake by stimulating POMC neurons in 
the brain. 
Leptin - Leptin is a 16 kDalton peptide synthesized 
by adipocytes, its main source being adipose tissue. Early 
experiments in rodents revealed that the absence of leptin causes 
obesity in the ob/ob mouse. Leptin has antagonist actions on 
NPY, melanin concentrating hormone (MCH) and AgRP which 
results in an increase of NPY concentration and augmented 
appetite. The anorectic neuropeptides that are up-regulated by 
leptin are POMC, CART and corticotrophin releasing hormone. 
Early research has proved Recombinant leptin therapy 
successful in humans with an extreme obese phenotype.In 
normal population, women have higher serum levels than men 
indicating an increased fat mass in women34. Leptin levels 
are low during fasting state but increase following the food 
intake. In obese individuals leptin has a diminished effect at its 
hypothalamic target which results in leptin resistance35. Leptin 
levels are increased by insulin and cortisol. However, when 
leptin acts with insulin centrally, together they bring satiety by 
stimulating POMC and preventing NPY action36.
Adiponectin - It is a 244- amino acid protein secreted from 
adipose tissue. The hormone, Adiponectin is produced by fat cells 
in inverse proportion to the body fat. The molecule is postulated 
to regulate energy homeostasis. It regulates metabolic functions 
of glucose regulation and fatty acid catabolism. The adiponectin 
receptors also control the metabolic rate at cellular level by 
targeting AMP-activated protein Kinase (AMPK), downstream. 
The enzyme, AMPK is activated by diminished Adenosine 
triphosphate (ATP) or increased Adenosine monophosphate 
186
JAIN and SINgH: DEF. LIFE SCI. J., VOL. 3, NO. 2, APRIL 2018, DOI : 10.14429/dlsj.3.12401
(AMP) levels. Sequentially, this activates catabolic processes 
like fatty acid breakdown and glycolysis and closes ATP-
consuming processes such as lipogenesis37. Studies show that 
expression of these receptors and also plasma adiponectin levels 
correlate with insulin levels38. Calorie restriction in rodents and 
weight loss due to calorie deficit diets have shown to increase 
adiponectin levels significantly. According to Shklyaev39, et 
al. the effects that adiponectin exerts are improving insulin 
resistance, glucose metabolism that are not completely 
understood but are thought to be mediated through metabolic 
pathways of gluconeogensis, lipogenesis and through regulation 
of food intake. With the persistent associations of adiponectin 
with obesity and diabetes, studies now support the molecule as 
a potent antidiabetic hormone40.
Insulin - Insulin along with leptin positively correlates 
with adipose tissue mass within the body. It is believed to 
have a similar lipostatic role to that of leptin. Similar to leptin, 
circulating insulin levels are proportional to the degree of 
adiposity41. Insulin is synthesized by β cells in the pancreas. Its 
release is induced in response to elevated glucose and amino 
acid concentrations. Through the blood brain barrier insulin 
reaches the hypothalamus and the receptors regulate glucose 
homeostasis. This is achieved by hormone binding to its cell 
surface receptors42. Lipid metabolism is also influenced, by 
increased lipid synthesis in adipocytes43High insulin levels are 
found in over weight individuals generally, though it is also 
considered that adiposity might in fact be a consequence of 
insulin resistance itself. Both insulin and leptin resistance exists 
in obese people mostly. 
3.7  Endocrine Markers of nutritional status 
Insulin like growth Factor-1
IgF-1 is a small peptide hormone about 7.5 kDa present 
in the blood at high concentrations structurally resembling 
proinsulin. Liver in response to high calorie intakes also increase 
its production. IgF-1 in the liver cells maintains blood glucose 
homeostasis for glycogen synthesis. The levels of IgF-1 are 
regulated by nutritional status and energy intake. Low IgF-1 
levels are seen in fasting and signify catabolism. Decline in 
serum IgF-1 levels and IgFBP-3 levels have also been seen on 
50 per cent reduction in calorie intake and 30 per cent reduction 
in protein intake44. IGF-1 may indirectly influence hunger by 
inhibiting leptin through IgFBP-1 levels45.
Thyroid hormones - Thyroid hormones and glucocorticoids 
both have a role in the regulation of energy homeostasis. Thyroid 
hormones are known to regulate energy expenditure through 
effects on basal metabolism and adaptive thermogenesis. Thyroid 
hormones in brown adipose tissue (BAT) are essential for diet-
induced thermogenesis. In addition to effects on heat generation, 
thyroid hormone has effects on lipogenesis and appetite 
regulation. Studies show that HPT axis may have outcomes 
on appetite control unrelated to energy expenditure. Typically, 
thyroid-stimulating hormone (TSH) released from the anterior 
pituitary gland, stimulates the secretion of triodothyronine 
(T3) and thyroxine (T4). These peptides can directly influence 
food intake46. Local regulation of thyroid hormones in the CNS 
may physiologically regulate appetite. More research needs 
to be done to identify the mechanisms through which thyroid 
hormones regulate energy balance. T3 increases expression of 
genes coding for lipogenic enzymes such as malic enzyme, 
glucose 6-phosphate dehydrogenase and acetyl-coenzyme A 
carboxylase47 that use fatty acids derived from adipose tissue 
as the primary source of substrate and is well known to increase 
food intake. 
Corticosterone - Any disturbance in the body evokes 
a stress response. Corticosterone controls sensitivity of the 
system’s response to stress and maintains the basal activity of 
the HPA axis thereby coordinating sleep/awake cycle, food 
intake, etc. It increases hepatic gluconeogenesis, and also 
increases cellular concentrations of enzymes and the substrates 
for gluconeogenesis48. Along with the established effects of 
glucocorticoids on blood glucose, corticosterone has also shown 
to directly inhibit insulin release from pancreatic β cells.This 
transitory decrease of the insulin response to hyperglycemia, 
may possibly be a regulatory mechanism to meet the glucose 
needs of the brain during stress49. glucocorticoids also have a 
role in adipose tissue and regulate several processes including 
metabolic activity, production and secretion of leptin. In the 
recent years, the effects of excess or reduced corticosterone 
levels in adipose tissue have been extensively studied. The 
evidence of the effects of corticosterone on food intake is 
controversial. Levay50, et al. showed that calorie restriction of 
different levels results in increased serum corticosterone in a 
dose-response trend in adult rats. In another study, higher levels 
of plasma corticosterone and lower levels of plasma ACTH 
were found in calorie-restricted rats compared with isolated or 
group-caged controls, during the light phase of the daily cycle. 
Higher levels of plasma corticosterone and lower levels of 
plasma ACTH were found in calorie-restricted rats compared 
with isolated or group-caged controls. However, as observed 
in precocial chicks corticosterone treatment may also affect 
growth by reducing appetite51 and possibly increase maintenance 
of energy expenditure. The glucocorticoid in man, cortisol has 
been known to increase leptin levels, stimulate insulin secretion 
and promote gluconeogenesis but decrease insulin sensitivity. 
4.  conclusIon
This paper elucidated the mechanisms that are involved in 
appetite control. The three phases of any meal viz. the initiation 
of food intake, duration of meal and end of the meal act as 
crucial points for meal regulation, in turn controlled by stomach 
contractions, internal and external mechanisms and specialized 
chemo- and mechano-receptors. Appetite regulation requires 
a balance of processes occurring at the brain, digestive tract 
and adipose tissue, much regulated centrally by the brain stem 
and hypothalamus. Peptides from the gut and adipose tissue, 
control energy balance. In addition, the urge or reluctance to 
eat or not eat, are governed by the tonic and episodic signals. 
To a large extent, environmental cues and life style factors 
create an obesigenic environment for the individual. For these 
reasons, to control the epidemic of obesity, the intricate process 
of appetite regulation has to be understood so as to effectively 
utilize the targeted pharmacological or therapeutic agents for 
obesity. 
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